Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Beryl Drugs Ltd.
Swot
Beryl Drugs Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Beryl Drugs Ltd. has 9 Strengths, 15 Weaknesses, 0 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(9)
Weakness
(15)
Opportunity
(0)
Threats
(0)
Others
(3)
Consistent Highest Return Stocks over Five Years - Nifty500
PEG lower than Industry PEG
Effectively using its capital to generate profit - RoCE improving in last 2 years
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Company with Zero Promoter Pledge
Top Gainers
PE higher than Industry PE
High PE (PE > 40)
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Oversold by Money Flow Index (MFI)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Degrowth in Revenue and Profit
Declining Revenue every quarter for the past 2 quarters
Declining Net Cash Flow : Companies not able to generate net cash
Major fall in TTM Net Profit
Fall in Quarterly Revenue and Net Profit (YoY)
Weak performer : Stock lost more than 20% in 1 month
Weak Momentum: Price below Short, Medium and Long Term Averages
Increasing Trend in Non-Core Income
RSI indicating price weakness
Stocks Underperforming their Industry Price Change in the Quarter
High Piotroski Score - Companies with strong financials
Rising Delivery Percentage Compared to Prev Day
Bullish or Bearish Candlestick Strength - Indices
